Request Deal Involvement
Double Point Ventures, Bioluminescence Ventures and Earlybird Venture Capital led a $34m funding round in GEMMA Biotherapeutics.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
DC Advisory
or
Principals
target
GEMMA BIOTHERAPEUTICS
bidder
DOUBLE POINT VENTURES LLC
bidder
BIOLUMINESCENCE VENTURES
bidder
EARLYBIRD VENTURE CAPITAL GMBH
bidder
SAVANNE LIFE SCIENCES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite